Alexandra Gould
Director of Chemistry, Center for the Development of Therapeutics, Broad Institute of MIT and Harvard
Sandy (Alexandra) Gould is the director of medicinal chemistry at the Center for the Development of Therapeutics (CDoT) at the Broad Institute of MIT and Harvard. Her group focuses on designing and implementing strategies for the development of novel therapeutics for cancer, psychiatric disorders, inflammatory and metabolic disorders, and rare diseases. Prior to joining the Broad, she spent 23 years at Takeda Pharmaceuticals (formerly Millennium Pharmaceuticals, Inc.) where she contributed to several oncology and immuno-oncology projects, and led an industry/NGO/academic collaboration focused on identifying and developing anti-malaria drugs with novel mechanisms of action.